Results 231 to 240 of about 242,272 (375)
What's New? Currently, no published data on homologous recombination deficiency (HRD) testing in the setting of molecular tumor boards exist. This study in a cohort of 237 patients encompassing 24 different tumor entities assessed by a molecular tumor board shows that inactivating alterations of BRCA1/2 are not always associated with an elevated ...
Christoph Schubart+26 more
wiley +1 more source
Genetic background and biliary atresia. [PDF]
Meng Y, Yang Q, Liu S, Ke X, Zhan J.
europepmc +1 more source
What's New? Exposures and mechanisms that contribute to and promote pancreatic ductal adenocarcinoma (PDAC) remain unclear. In this study, the authors applied metabolomics to better understand PDAC etiology by examining associations between prediagnostic serum metabolites and PDAC risk.
Ting Zhang+7 more
wiley +1 more source
Results of treatment of patients with gallstone disease and ductal calculi by single-stage laparoscopic cholecystectomy and bile duct exploration [PDF]
Eryk Naumowicz+2 more
openalex +1 more source
Ascitic fluid concentrations of fibronectin and cholesterol [PDF]
Gerbes, Alexander L.+3 more
core
The study investigated the longitudinal effects of normal and high‐fat diet, showing their differential effects on gut microbiota diversity and gut metabolites, with the latter having a significant impact on increasing liver inflammation and gut microbiota and metabolites disruption.
Qian Gong+7 more
wiley +1 more source
A Novel Bioabsorbable Covered Stent for Advancing Bile Duct Injury Management: A Preclinical Study in a Porcine Model (With Video). [PDF]
Miyazawa M+6 more
europepmc +1 more source
Patient‐derived xenograft models in pan‐cancer: From bench to clinic
Abstract Patient‐derived xenograft (PDX) models provide a robust preclinical platform that preserves the genetic and phenotypic heterogeneity of patient tumors while mirroring their tumor genetic characteristics, which retain malignant cells and the tumor pathological structure, making them valuable for studying tumor progression and developing ...
Jiatong Li+5 more
wiley +1 more source